Business
Ondine to present new AMR research at ICPIC Geneva
Ondine to present new AMR research at ICPIC Geneva.
About this update from Ondine Biomedical, Inc.
[{"type":"text","content":"\n\n29 August 2023\nONDINE BIOMEDICAL INC. \n(\"Ondine Biomedical\", \"Ondine\" or the \"Company\") \nOndine to present new AMR research at ICPIC, Geneva\nOndine Biomedical to present new research on efficacy of photodisinfection against key gram-negative bacteria driving antimicrobial resistance threat\nCanadian life sciences company Ondine Biomedical Inc. (LON: OBI) will present new research on the efficacy of antimicrobial photodynamic therapy, known as photodisinfection, against extensively drug-resistant gram-negative bacteria at the 7th International Consortium on Prevention & Infection Control (ICPIC) taking place in Geneva, from 12-15 September 2023. ICPIC is a leading international conference on the prevention of healthcare-associated infection and the control of antimicrobial resistance around the world.\nAntimicrobial resistance (AMR) poses an urgent global public health threat. The US has shown an alarming increase of 35% in AMR Enterobacteriaceae infections[i] and analysis published in The Lancet found that 1.27 million deaths worldwide in 2019 were the direct result of drug-resistant bacterial infections.[ii] Extensively drug-resistant (XDR) bacteria are a particularly concerning category of multidrug-resistant organisms that are proving resistant to almost all or all approved antimicrobial agents.[iii]\nDr. Nicolas Loebel, Ondine's CTO and President, commented:\n\"Overuse of antibiotics over decades has caused adaptation in many microbes, and we now see multidrug resistance (MDR) evolving into extensive drug resistance (XDR) in bacteria, rendering even the most powerful drugs ineffective. We believe photodisinfection can play a significant role in cost effectively combatting these drug-resistant pathogens and reducing global reliance on antibiotics.\"\nPhotodisinfection is an easy-to-use alternative to antibiotics and antifungals, including MDR and XDR strains, because it is highly effective against all types of disease-causing pathogens and, as a non-biological treatment, does not generate resistance.\nOndine's photodisinfection is a patented technology using a proprietary photosensitizer that when illuminated with a specific wavelength of non-thermal red light, causes an oxidative burst that produces reactive oxygen species that are lethal to bacteria, fungi, algae, protozoa and viruses, by u...